2024 Q2 Form 10-Q Financial Statement

#000003877724000069 Filed on April 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $2.123B $2.153B $1.991B
YoY Change 7.82% 11.71% 1.22%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $661.2M $1.820B $532.8M
YoY Change -56.95% 230.25% -0.37%
% of Gross Profit
Research & Development $156.6M $155.1M $131.0M
YoY Change 23.02% 21.17% 7.91%
% of Gross Profit
Depreciation & Amortization $113.0M $116.4M $25.70M
YoY Change 1.99% 2.28% 2.39%
% of Gross Profit
Operating Expenses $1.900B $1.905B $1.785B
YoY Change 17.22% 13.9% 0.65%
Operating Profit $222.5M $129.3M $206.5M
YoY Change -29.34% -49.31% 6.44%
Interest Expense $25.70M $104.8M $18.80M
YoY Change 558.97% 212.84% -39.16%
% of Operating Profit 11.55% 81.05% 9.1%
Other Income/Expense, Net $77.60M $4.000M $124.7M
YoY Change 483.46% -97.73% 255.27%
Pretax Income $300.1M $238.1M $331.2M
YoY Change -9.64% -44.76% 44.57%
Income Tax $68.10M $62.80M $74.90M
% Of Pretax Income 22.69% 26.38% 22.61%
Net Earnings $174.0M $117.0M $251.3M
YoY Change -19.93% -39.75% 51.75%
Net Earnings / Revenue 8.2% 5.43% 12.62%
Basic Earnings Per Share $0.32 $0.23 $0.50
Diluted Earnings Per Share $0.32 $0.23 $0.50
COMMON SHARES
Basic Shares Outstanding 526.1M shares 526.6M shares 494.6M shares
Diluted Shares Outstanding 517.2M shares 519.2M shares 487.9M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.112B $4.124B $3.880B
YoY Change -6.29% -3.61% -13.83%
Cash & Equivalents $4.112B $4.124B $3.880B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $1.571B $1.450B $1.470B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.682B $5.574B $5.349B
YoY Change -0.83% -0.1% -7.68%
LONG-TERM ASSETS
Property, Plant & Equipment $904.8M $1.795B $807.0M
YoY Change -26.86% 139.42% 6.2%
Goodwill $6.199B $6.199B $6.013B
YoY Change 3.1% 3.19% 1.18%
Intangibles $5.268B $5.331B $4.823B
YoY Change 5.46% 5.15% -6.43%
Long-Term Investments $1.227B $13.53B $1.156B
YoY Change -89.68% 1088.54% 39.18%
Other Assets
YoY Change
Total Long-Term Assets $27.57B $27.33B $24.52B
YoY Change 12.52% 16.28% 4.14%
TOTAL ASSETS
Total Short-Term Assets $5.682B $5.574B $5.349B
Total Long-Term Assets $27.57B $27.33B $24.52B
Total Assets $33.25B $32.91B $29.87B
YoY Change 9.99% 13.14% 1.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.249B $1.318B $1.001B
YoY Change 10.62% 34.61% -16.52%
Accrued Expenses $2.667B $2.396B $2.029B
YoY Change 36.37% 38.57% 27.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $57.30M $191.5M
YoY Change
Total Short-Term Liabilities $4.356B $4.239B $3.650B
YoY Change 23.28% 32.67% 5.46%
LONG-TERM LIABILITIES
Long-Term Debt $12.62B $11.98B $10.89B
YoY Change 11.17% 13.91% 14.17%
Other Long-Term Liabilities $961.0M $1.415B $1.220B
YoY Change -26.85% -13.22% -21.09%
Total Long-Term Liabilities $13.58B $13.40B $12.11B
YoY Change 7.23% 10.27% 9.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.356B $4.239B $3.650B
Total Long-Term Liabilities $13.58B $13.40B $12.11B
Total Liabilities $18.35B $20.05B $16.15B
YoY Change 0.37% 27.83% 9.12%
SHAREHOLDERS EQUITY
Retained Earnings $12.32B $12.27B $12.40B
YoY Change -0.32% 0.04% 2.39%
Common Stock $1.037B $1.075B $49.50M
YoY Change 1977.76% 2045.51% -1.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.87B $12.86B $12.00B
YoY Change
Total Liabilities & Shareholders Equity $33.25B $32.91B $29.87B
YoY Change 9.99% 13.14% 1.81%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income $174.0M $117.0M $251.3M
YoY Change -19.93% -39.75% 51.75%
Depreciation, Depletion And Amortization $113.0M $116.4M $25.70M
YoY Change 1.99% 2.28% 2.39%
Cash From Operating Activities $528.4M $136.6M -$251.9M
YoY Change -19.33% -508.98% -1.72%
INVESTING ACTIVITIES
Capital Expenditures $46.10M $41.70M $19.50M
YoY Change -41.42% 170.78% -28.83%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$765.8M -$231.5M -$118.1M
YoY Change -21.66% -79.64% -88.37%
Cash From Investing Activities -$811.9M -$273.2M -$137.6M
YoY Change -23.13% -76.29% -86.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 274.3M 391.1M -$159.0M
YoY Change -45.62% -59.33% -116.58%
NET CHANGE
Cash From Operating Activities 528.4M 136.6M -$251.9M
Cash From Investing Activities -811.9M -273.2M -$137.6M
Cash From Financing Activities 274.3M 391.1M -$159.0M
Net Change In Cash -9.200M 254.5M -$522.8M
YoY Change -108.91% -213.57% 86.51%
FREE CASH FLOW
Cash From Operating Activities $528.4M $136.6M -$251.9M
Capital Expenditures $46.10M $41.70M $19.50M
Free Cash Flow $482.3M $94.90M -$271.4M
YoY Change -16.31% -294.47% -4.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
495937891 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
495937891 shares
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12298900000 usd
CY2022Q4 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
169100000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
124700000 usd
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2022Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
153600000 usd
CY2022Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
14200000 usd
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33600000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35600000 usd
CY2022Q4 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
97100000 usd
CY2022Q4 ben Consolidation Deconsolidation Of Investment Products
ConsolidationDeconsolidationOfInvestmentProducts
-35700000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12555500000 usd
CY2023Q1 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
189900000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
17900000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
153800000 usd
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
3600000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25300000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40800000 usd
CY2023Q1 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
50100000 usd
CY2023Q1 ben Consolidation Deconsolidation Of Investment Products
ConsolidationDeconsolidationOfInvestmentProducts
-324200000 usd
CY2023Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
44700000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12442600000 usd
us-gaap Profit Loss
ProfitLoss
431600000 usd
us-gaap Profit Loss
ProfitLoss
440700000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
132000000.0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
122000000.0 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
28300000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
25000000.0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57500000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
52900000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
170400000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
169200000 usd
ben Net Gains Losses On Investments
NetGainsLossesOnInvestments
41600000 usd
ben Net Gains Losses On Investments
NetGainsLossesOnInvestments
48500000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
81300000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
52600000 usd
ben Gains Losses On Investments Of Consolidated Investment Products
GainsLossesOnInvestmentsOfConsolidatedInvestmentProducts
3000000.0 usd
ben Gains Losses On Investments Of Consolidated Investment Products
GainsLossesOnInvestmentsOfConsolidatedInvestmentProducts
-57500000 usd
ben Purchase And Liquidation Of Investments By Consolidated Investment Products
PurchaseAndLiquidationOfInvestmentsByConsolidatedInvestmentProducts
232200000 usd
ben Purchase And Liquidation Of Investments By Consolidated Investment Products
PurchaseAndLiquidationOfInvestmentsByConsolidatedInvestmentProducts
613000000.0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15000000.0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-55700000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-57400000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-28800000 usd
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
55100000 usd
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
144400000 usd
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-10000000.0 usd
us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
36000000.0 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-316000000.0 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-336100000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-177200000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-28500000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
22600000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
85400000 usd
ben Increase Decrease In Other Operating Liabilities Of Consolidated Investment Products
IncreaseDecreaseInOtherOperatingLiabilitiesOfConsolidatedInvestmentProducts
-103700000 usd
ben Increase Decrease In Other Operating Liabilities Of Consolidated Investment Products
IncreaseDecreaseInOtherOperatingLiabilitiesOfConsolidatedInvestmentProducts
3700000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-115300000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-329600000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
501000000.0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
504700000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
543600000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
385400000 usd
ben Purchase Of Investments By Consolidated Collateralized Loan Obligations
PurchaseOfInvestmentsByConsolidatedCollateralizedLoanObligations
2294300000 usd
ben Purchase Of Investments By Consolidated Collateralized Loan Obligations
PurchaseOfInvestmentsByConsolidatedCollateralizedLoanObligations
2097600000 usd
ben Liquidation Of Investments By Consolidated Collateralized Loan Obligations
LiquidationOfInvestmentsByConsolidatedCollateralizedLoanObligations
1769900000 usd
ben Liquidation Of Investments By Consolidated Collateralized Loan Obligations
LiquidationOfInvestmentsByConsolidatedCollateralizedLoanObligations
618800000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
61200000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42800000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-177900000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
500500000 usd
ben Payments Of Contingent Consideration Asset
PaymentsOfContingentConsiderationAsset
0 usd
ben Payments Of Contingent Consideration Asset
PaymentsOfContingentConsiderationAsset
5500000 usd
ben Payments Of Deferred Consideration Liability
PaymentsOfDeferredConsiderationLiability
60800000 usd
ben Payments Of Deferred Consideration Liability
PaymentsOfDeferredConsiderationLiability
0 usd
ben Cash And Cash Equivalents Increase Decrease Due To Consolidation And Deconsolidation Of Investment Products
CashAndCashEquivalentsIncreaseDecreaseDueToConsolidationAndDeconsolidationOfInvestmentProducts
15100000 usd
ben Cash And Cash Equivalents Increase Decrease Due To Consolidation And Deconsolidation Of Investment Products
CashAndCashEquivalentsIncreaseDecreaseDueToConsolidationAndDeconsolidationOfInvestmentProducts
-85400000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-410800000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2221300000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7300000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13400000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
321400000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
301800000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
70500000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
17800000 usd
us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
0 usd
us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
174800000 usd
ben Proceeds From Issuance Of Debt By Consolidated Investment Products
ProceedsFromIssuanceOfDebtByConsolidatedInvestmentProducts
587400000 usd
ben Proceeds From Issuance Of Debt By Consolidated Investment Products
ProceedsFromIssuanceOfDebtByConsolidatedInvestmentProducts
2258700000 usd
ben Payments On Debt By Consolidated Investment Products
PaymentsOnDebtByConsolidatedInvestmentProducts
35500000 usd
ben Payments On Debt By Consolidated Investment Products
PaymentsOnDebtByConsolidatedInvestmentProducts
688300000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
2900000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4200000 usd
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
552000000.0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-278100000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4402400000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4782500000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
318400000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
204600000 usd
us-gaap Interest Paid Net
InterestPaidNet
51300000 usd
us-gaap Interest Paid Net
InterestPaidNet
47100000 usd
ben Cash Interest Paid By Consolidated Investment Products
CashInterestPaidByConsolidatedInvestmentProducts
345600000 usd
ben Cash Interest Paid By Consolidated Investment Products
CashInterestPaidByConsolidatedInvestmentProducts
128600000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
124200000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
194200000 usd
us-gaap Net Income Loss
NetIncomeLoss
375500000 usd
us-gaap Net Income Loss
NetIncomeLoss
359800000 usd
CY2024Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
7200000 usd
CY2024Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
7200000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
9000000.0 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
9000000.0 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
16300000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
16300000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
16700000 usd
us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
16700000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
117000000.0 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
117000000.0 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
185200000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
185200000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
359200000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
359200000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
343100000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
343100000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
518400000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
490700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
502600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
490100000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
800000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
700000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
800000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
700000 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
519200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
491400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
503400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
490800000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.71
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.70
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2152800000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4143900000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1927200000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3894300000 usd
ben Revenue From Sponsored Funds
RevenueFromSponsoredFunds
0.83
ben Revenue From Sponsored Funds
RevenueFromSponsoredFunds
0.83
CY2023Q1 ben Revenue From Sponsored Funds
RevenueFromSponsoredFunds
0.83
CY2024Q1 ben Revenue From Sponsored Funds
RevenueFromSponsoredFunds
0.83
CY2024Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
899700000 usd
CY2023Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
872800000 usd
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
1216700000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
1089200000 usd
CY2024Q1 us-gaap Other Investments
OtherInvestments
261300000 usd
CY2023Q3 us-gaap Other Investments
OtherInvestments
260000000.0 usd
CY2024Q1 us-gaap Investments
Investments
2377700000 usd
CY2023Q3 us-gaap Investments
Investments
2222000000 usd
CY2024Q1 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
150600000 usd
CY2024Q1 us-gaap Securities Borrowed Fair Value Of Collateral
SecuritiesBorrowedFairValueOfCollateral
158200000 usd
CY2024Q1 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
43100000 usd
CY2023Q3 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments
43100000 usd
CY2024Q1 ben Number Of Consolidated Investmentproducts
NumberOfConsolidatedInvestmentproducts
81 cips
CY2024Q1 ben Number Of Collateralized Obligation Consolidated Deconsolidated
NumberOfCollateralizedObligationConsolidatedDeconsolidated
22 cips
CY2023Q3 ben Number Of Consolidated Investmentproducts
NumberOfConsolidatedInvestmentproducts
70 cips
CY2023Q3 ben Number Of Collateralized Obligation Consolidated Deconsolidated
NumberOfCollateralizedObligationConsolidatedDeconsolidated
20 cips
CY2023Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
396600000 usd
CY2024Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P16Y
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
707300000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
15881000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
23.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
12271000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1279000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
23.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
573000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
21.87
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
26300000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.40
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
314300000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2024Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
38000000.0 usd
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
32300000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
92800000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
68800000 usd
CY2024Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-18500000 usd
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
3000000.0 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
41600000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
48500000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24400000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
20600000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
81300000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
52600000 usd
CY2024Q1 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
10900000 usd
CY2023Q1 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
13400000 usd
us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
21700000 usd
us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
24000000.0 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1300000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6500000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-8700000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-33600000 usd
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1000000.0 usd
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2200000 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
3000000.0 usd
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
9800000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
52500000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
60600000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
225700000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
150500000 usd
CY2024Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
9500000 usd
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
86100000 usd
CY2023Q1 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
13100000 usd
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
78200000 usd

Files In Submission

Name View Source Status
0000038777-24-000069-index-headers.html Edgar Link pending
0000038777-24-000069-index.html Edgar Link pending
0000038777-24-000069.txt Edgar Link pending
0000038777-24-000069-xbrl.zip Edgar Link pending
ben-20240331.htm Edgar Link pending
ben-20240331.xsd Edgar Link pending
exhibit311q2fy24.htm Edgar Link pending
exhibit312q2fy24.htm Edgar Link pending
exhibit321q2fy24.htm Edgar Link pending
exhibit322q2fy24.htm Edgar Link pending
ben-20240331_cal.xml Edgar Link unprocessable
ben-20240331_def.xml Edgar Link unprocessable
ben-20240331_lab.xml Edgar Link unprocessable
ben-20240331_pre.xml Edgar Link unprocessable
ben-20240331_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable